When the HIF-1α mRNA levels were analyzed, they were found to be significantly lower in the PCa+LDH-A inhibitor + Docetaxel treatment group compared to the PCa group (p < 0.05) (Figure 7). This evidence concerns the gene LDHA and posterior cortical atrophy.